Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oncimmune Holdings PLC (DE:OCY)
STUTTGART:OCY
Holding DE:OCY?
Track your performance easily
OCY Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.10 - €0.33
Previous Close€0.19
Volume0.00
Average Volume (3M)N/A
Market Cap
€15.51M
Enterprise Value€18.02M
Total Cash (Recent Filing)£3.21M
Total Debt (Recent Filing)£5.30M
Price to Earnings (P/E)―
Beta1.06
Next Earnings
Feb 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Oncimmune Holdings News
PremiumCompany Announcements
Oncimmune Sees Surge in Commercial Growth
PremiumCompany Announcements
Oncimmune Clinches New Pharma Contract, Targets Profitability
PremiumCompany Announcements
Oncimmune Clinches Major $1.5M Pharma Contract
PremiumCompany Announcements
Spreadex Adjusts Stake in Oncimmune Holdings
PremiumCompany Announcements
Spreadex LTD Adjusts Stake in Oncimmune HoldingsPremiumCompany Announcements
Oncimmune Holdings Shareholding Shift by Spreadex LTD
PremiumCompany Announcements
Oncimmune Sees Revenue Growth and Strategic Gains
PremiumCompany Announcements
Oncimmune Holdings Unveils Upcoming Investor PresentationOptions Prices
Currently, No data available
---
Ownership Overview
19.99% Insiders
<0.01% Mutual Funds
0.00% Other Institutional Investors
80.01% Public Companies and
Individual Investors
OCY FAQ
What was Oncimmune Holdings PLC’s price range in the past 12 months?
Oncimmune Holdings PLC lowest stock price was €0.10 and its highest was €0.33 in the past 12 months.
What is Oncimmune Holdings PLC’s market cap?
Currently, no data Available
When is Oncimmune Holdings PLC’s upcoming earnings report date?
Oncimmune Holdings PLC’s upcoming earnings report date is Feb 27, 2025 which is in 154 days.
How were Oncimmune Holdings PLC’s earnings last quarter?
Oncimmune Holdings PLC released its earnings results on May 21, 2024. The company reported €0.132 earnings per share for the quarter, beating the consensus estimate of N/A by €0.132.
Is Oncimmune Holdings PLC overvalued?
According to Wall Street analysts Oncimmune Holdings PLC’s price is currently Overvalued.
Does Oncimmune Holdings PLC pay dividends?
Oncimmune Holdings PLC does not currently pay dividends.
What is Oncimmune Holdings PLC’s EPS estimate?
Oncimmune Holdings PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oncimmune Holdings PLC have?
Oncimmune Holdings PLC has 74,142,140 shares outstanding.
What happened to Oncimmune Holdings PLC’s price movement after its last earnings report?
Oncimmune Holdings PLC reported an EPS of €0.132 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 5.263%.
Which hedge fund is a major shareholder of Oncimmune Holdings PLC?
Currently, no hedge funds are holding shares in DE:OCY
---
Oncimmune Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-0.28%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-24.50%
Trailing 12-Months
Company Description
Oncimmune Holdings PLC
Oncimmune Holdings PLC is engaged in diagnosing cancer. It is involved in the development, manufacture, and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer. The company's operating segment includes EarlyCDT and ImmunoINSIGHTS. It generates maximum revenue from the EarlyCDT segment.
---
Technical Analysis
---